Skip to main content

Our roundup of Canadian small-caps of between $100-million and $3-billion in market capitalization making news

DRI Healthcare Trust (DHT-UN-T) announced it has acquired a royalty interest in worldwide sales of Xenpozyme (olipudase alfa) for US$30-million. The company said additional performance-based milestones of up to US$26.5-million could be paid if sales of the drug outperform expectations.

The company said Xenpozyme is the only product developed and approved for the treatment of non-central nervous system manifestations of acid sphingomyelinase deficiency (ASMD), also known as Niemann-Pick disease.

“Xenpozyme is a product that provides ASMD patients and their families with a disease-modifying therapy where none previously existed. The drug represents a transformational shift in therapies available to patients who suffer from ASMD,” said CEO Behzad Khosrowshahi.

**

Metalla Royalty & Streaming Ltd. (MTA-A) announced that it signed a royalty purchase agreement with First Majestic Silver Corp. (FR-T). Metalla said it will acquire eight royalties for $20-million of common shares of Metalla First Majestic holds and will originate a portfolio of royalties in Mexico.

**

Mene Inc. (MENE-X) reported revenue came in at $5-million for the third quarter, compared to $5.3-million a year ago. Net income of $1-illion compared to $551,723 a year ago.

**

NGEx Minerals Ltd. (NGEX-X) reported a net loss of $6.1-million or 4 cents per share during the three months ended Sept. 30 versus a net loss of $1.5-million or a penny per share a year ago.

Report an editorial error

Report a technical issue

Editorial code of conduct

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 21/02/24 11:59pm EST.

SymbolName% changeLast
MENE-X
Mene Inc
+0.95%0.212
NGEX-X
Ngex Minerals Ltd
+7.01%8.24
DHT-UN-T
Dri Healthcare Trust
-1.18%15.95
MTA-A
Metalla Royalty and Streaming Ltd
+2.96%3.13
FR-T
First Majestic Silver Corp Common
+4.62%7.93

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe